1. Home
  2. QTRX vs MAV Comparison

QTRX vs MAV Comparison

Compare QTRX & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • MAV
  • Stock Information
  • Founded
  • QTRX 2007
  • MAV 2003
  • Country
  • QTRX United States
  • MAV United States
  • Employees
  • QTRX N/A
  • MAV N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • MAV Finance Companies
  • Sector
  • QTRX Industrials
  • MAV Finance
  • Exchange
  • QTRX Nasdaq
  • MAV Nasdaq
  • Market Cap
  • QTRX 233.5M
  • MAV 197.1M
  • IPO Year
  • QTRX 2017
  • MAV N/A
  • Fundamental
  • Price
  • QTRX $6.26
  • MAV $8.08
  • Analyst Decision
  • QTRX Buy
  • MAV
  • Analyst Count
  • QTRX 4
  • MAV 0
  • Target Price
  • QTRX $13.50
  • MAV N/A
  • AVG Volume (30 Days)
  • QTRX 639.3K
  • MAV 66.2K
  • Earning Date
  • QTRX 08-07-2025
  • MAV 01-01-0001
  • Dividend Yield
  • QTRX N/A
  • MAV 4.30%
  • EPS Growth
  • QTRX N/A
  • MAV N/A
  • EPS
  • QTRX N/A
  • MAV N/A
  • Revenue
  • QTRX $135,688,000.00
  • MAV N/A
  • Revenue This Year
  • QTRX N/A
  • MAV N/A
  • Revenue Next Year
  • QTRX $14.28
  • MAV N/A
  • P/E Ratio
  • QTRX N/A
  • MAV N/A
  • Revenue Growth
  • QTRX 7.71
  • MAV N/A
  • 52 Week Low
  • QTRX $4.05
  • MAV $6.37
  • 52 Week High
  • QTRX $16.01
  • MAV $8.34
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 53.38
  • MAV 36.59
  • Support Level
  • QTRX $5.44
  • MAV $8.06
  • Resistance Level
  • QTRX $6.60
  • MAV $8.36
  • Average True Range (ATR)
  • QTRX 0.39
  • MAV 0.04
  • MACD
  • QTRX 0.05
  • MAV -0.01
  • Stochastic Oscillator
  • QTRX 70.20
  • MAV 23.33

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About MAV Pioneer Municipal High Income Advantage Fund Inc.

Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax, and as a secondary objective, to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.

Share on Social Networks: